Amanda Scott Williamson

I'll research this attorney before drafting.

Amanda S. Williamson — Morgan, Lewis & Bockius (Chicago)

Specialty / focus. Williamson's practice centers on complex IP litigation in the life sciences — pharmaceuticals, biologics, biosimilars, and medical devices — including products on the market and newly launched products. Her firm biography also lists work in inkjet printing, RFID-enabled devices, networked devices and related software, cellular devices, and standard-essential wireless technologies. Published examples of her matters include a hemophilia bispecific antibody suit in D. Del., a 33-patent inkjet printer campaign in W.D. Tex., RFID and printer-networking disputes in N.D. Ill., a 19-patent multidistrict cellular/standard-essential-patent litigation with a companion Section 337 investigation, and ITC work concerning recombinant factor VIII manufacturing. Her technical background is in chemistry.

Side preference. The tracked data reflect a single appearance, on the defendant side, as lead counsel. Web-verifiable matters show a genuinely mixed portfolio rather than a one-sided one: she has represented patent holders and plaintiffs (e.g., Nippon Shinyaku in D. Del. and on appeal; Canon as IPR petitioner), and has defended operating companies (e.g., Canon U.S.A. against Slingshot Printing's infringement suits). There is no indication of NPE/PAE-side prosecution work; her clients are operating companies and patent owners in the life sciences and printing/electronics sectors. Because the tracked case entry is unlabeled, it cannot be tied to a specific named matter.

Notable matters. Nippon Shinyaku Co. v. Sarepta Therapeutics (D. Del.; Fed. Cir. 2021-2369) is her most prominent appellate result: the Federal Circuit reversed a denial of a preliminary injunction and held that a forum-selection clause in the parties' mutual confidentiality agreement barred Sarepta from pursuing seven IPRs, ordered the injunction entered, and issued a precedential opinion (25 F.4th 998 (Fed. Cir. 2022)). LMG Life Sciences recognized the firm with a "Patent Impact Cases of the Year" award for that win, with Williamson leading the team. She has also been part of Morgan Lewis's appellate team for Canon in the long-running Slingshot Printing inkjet dispute, which has produced a series of Federal Circuit affirmances upholding PTAB obviousness holdings (e.g., Nos. 24-1956, 24-2127, 24-2132, 25-1033/1034, 2026); the firm reported those as its fifth successful Federal Circuit outcome for Canon in that dispute.

PTAB / IPR. She appears regularly in post-grant proceedings. She is counsel of record for Canon in multiple Canon v. Slingshot IPRs (IPR2022-01416, IPR2022-01541, IPR2023-00312/00313), took and defended expert depositions, and briefed the resulting Federal Circuit appeals. Her bio also lists IPR and ex parte reexamination experience, and she has presented on IPR/PGR practice for biologics and BPCIA "patent dance" issues.

Firm history, bar, education. She joined Morgan Lewis as a partner in Chicago in February 2016 from K&L Gates, along with three other IP partners. She is a registered USPTO practitioner (Reg. No. 73,683) and is admitted in Illinois (2003) and before the Federal Circuit and the Sixth, Seventh, and Eleventh Circuits. Education: Northwestern University (B.A., chemistry, 1998), Northwestern University School of Law (J.D., 2003), and Northwestern's Kellogg School of Management (M.B.A., 2003); she clerked for Judge James B. Zagel (N.D. Ill.). Industry recognition includes IAM Patent 1000 (2023–2025) and LMG Life Sciences "General Patent Litigator of the Year – Midwest" (2022). One caveat: a Martindale entry for this name lists a 2010 Alabama admission and unrelated practice areas; I could not corroborate that against firm or court sources, so I would not rely on it without further verification.